Search results
PROMOTED
Stay up to date with the latest clinical evidence in transthyretin amyloid cardiomyopathy (ATTR-CM) with this video series spotlighting key cardiomyopathy updates presented at ESC Heart Failure Congress (HFA) 2026.In the first session, Dr Mathew Maurer (Columbia University, New York, US) takes a deep dive into the CARDIO-TTRansform data, exploring the current treatment landscape and ongoing unmet…
View more
Spotlight on HFA 2026: Updates on Cardiomyopathies
Author(s):
Mathew S Maurer
,
Margot K Davis
Added:
3 weeks ago
Video Series
SGLT-2 Inhibitors and Heart Failure
Author(s):
C Noah Nilsson
,
Mads Kristian Ersbøll
,
Finn Gustafsson
Added:
1 year ago
Review Article
Aldosterone Synthase Inhibitors
Author(s):
Shubh K Patel
,
Hwee Teoh
,
Ahreni Saunthar
,
et al
Added:
9 months ago
Review Article
David Wheeler
Research Area(s) / Expertise:
Job title: Professor of Kidney Medicine
Author
Salvatore Carbone
Job title: PhD, RD, FHFSA, FASPEN
Author
ARNI for Optimising HFrEF Management
Author(s):
Massimo Iacoviello
,
Filippo M Sarullo
,
Claudio Bilato
,
et al
Added:
10 months ago
Expert Opinion
Author(s):
Added:
7 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview…
View more
Author(s):
Antonio Méndez-Durán
,
Juan B Ivey-Miranda
,
Genaro H Mendoza-Zavala
,
et al
Added:
1 month ago
Understanding the Role of GLP-1 RAs in the Treatment of HF
Author(s):
Giovanni Battista Bonfioli
,
Matteo Pagnesi
,
Daniela Tomasoni
,
et al
Added:
9 months ago
Review Article
Heart Failure Treatment and Cardiac Amyloidosis
Author(s):
Giorgia Panichella
,
Alberto Aimo
,
Vincenzo Castiglione
,
et al
Added:
10 months ago
Review Article
